Publication: Diversity in Dermatology Clinical Trials
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Medical Association (AMA)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Charrow, Alexandra, Fan Di Xia, Cara Joyce, and Arash Mostaghimi. 2017. “Diversity in Dermatology Clinical Trials.” JAMA Dermatology 153 (2) (February 1): 193. doi:10.1001/jamadermatol.2016.4129.
Research Data
Abstract
Question What is the racial, ethnic, and sex makeup of participants in randomized clinical trials of dermatologic conditions?
Findings In this systematic review of 626 trials conducted in 2010 through 2015, there was a low level of reporting of racial and ethnic composition of trial participants. Those US trials that reported race and ethnicity included a proportional number of women and African Americans compared with the general population, but Hispanic representation was lower than that of the general population of the United States.
Meaning While dermatologic clinical trials conducted in the United States are racially diverse, the field must increase reporting of race and ethnicity and strive for representative study cohorts especially with respect to ethnic diversity.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service